Donor Lymphocyte Infusion (DLI) is a valuable procedure in the post-transplant management of patients, supporting overall immune recovery, and fighting residual cancer cells and relapse. It involves i.....
Donor Lymphocyte Infusion (DLI) is a valuable procedure in the post-transplant management of patients, supporting overall immune recovery, and fighting residual cancer cells and relapse. It involves infusing lymphocytes, a type of white blood cell, from the original stem cell donor into the recipient after the initial transplant. It represents a significant advancement in the fight against relapse in haematologic malignancies and post-transplant viral infections. In half-match transplants, it is also used to enhance immune function in cases where the recipient's immune recovery is insufficient. Medanta’s in-house Blood Bank helps safe donation, storage and infusion under one roof.
